Skip to main content
×
×
Home

Ospolot—A Clinical Trial of a New Anticonvulsant

  • A. W. Griffiths (a1) and P. E. Sylvester (a1)
Extract

Ospolot is tetrahydro-2-p-sulphamoylphenyl-1, 2 thiazine 1, 1-dioxide, with a structural formula:

Copyright
References
Hide All
Engelmeier, M. P. (1960). “The clinical trial of anti-epileptic drugs, with special consideration of Ospolot.” Dtsch. med. Wsckr., 85, 2207.
Flügel, F. (1960). “The position of the butansultam derivative Ospolot in the treatment of cerebral convulsive diseases.” Ibid., 85, 2199.
Friebel, H., and Sommers, S. (1960). “Some aspects of the pharmacology of N-aryl-sultam compounds.” Ibid., 85, 2192.
Raffauf, H. J. (1960). “Treatment of cerebral convulsive diseases with Ospolot.” Ibid., 85, 2203.
Wirth, W. et al. (1960). “Some aspects of the pharmacology of Ospolot (N-4′-sulphamyl-phenyl-butansultam-1-4).” Ibid., 85, 2195.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

The British Journal of Psychiatry
  • ISSN: 0007-1250
  • EISSN: 1472-1465
  • URL: /core/journals/the-british-journal-of-psychiatry
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 2 *
Loading metrics...

Abstract views

Total abstract views: 21 *
Loading metrics...

* Views captured on Cambridge Core between 29th January 2018 - 25th June 2018. This data will be updated every 24 hours.

Ospolot—A Clinical Trial of a New Anticonvulsant

  • A. W. Griffiths (a1) and P. E. Sylvester (a1)
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *